Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

Tumor treating fields are emerging as a promising option for treating a range of cancer types. Here’s a look at the evidence ...

Pancreatic cancer remains the deadliest cancer due to late diagnosis and poor CT visibility, leaving just 10% alive at five years.

Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread ...

A new MD Anderson antibody, 77A, restores treatment response in resistant myeloma, lymphoma and solid tumors, offering a ...

A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist ...

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...

Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax(TM), dramatically reduces ...